Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-009345
Filing Date
2025-11-25
Accepted
2025-11-25 16:23:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5526
  Complete submission text file 0001950047-25-009345.txt   7148
Mailing Address 1500 BROADWAY SUITE 1401 NEW YORK NY 10036
Business Address 1500 BROADWAY SUITE 1401 NEW YORK NY 10036 332-208-6102
Nuvation Bio Inc. (Subject) CIK: 0001811063 (see all company filings)

EIN.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39351 | Film No.: 251521609
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NUVATION BIO INC. 1500 BROADWAY, SUITE 401 NEW YORK NY 10036
Business Address
Liu Dongfang (Reporting) CIK: 0001937915 (see all company filings)

Type: 144